SCHEMBL3672842

SCHEMBL3672842

CS(=O)(=O)Nc1ccccc1-c1c[nH]c(=O)c(-c2ccccc2C#N)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
GALR3 O60755 1/20 0.40
GAA P10253 1/20 0.40
PARP14 Q460N5 2/20 0.40
PLA2G7 Q13093 1/20 0.40
MCL1 Q07820 4/20 0.40
CDK1 P06493 1/20 0.39
CDK2 P24941 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
MDM2 Q00987 1/20 0.38
NR3C1 P04150 6/20 0.37
TNIK Q9UKE5 1/20 0.37
PGR P06401 4/20 0.36
NR3C2 P08235 4/20 0.36
AR P10275 4/20 0.36
PGAM1 P18669 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3681528 0.78 MCL1 (0.46) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL3667719 0.77 HTT (0.49) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL6695728 0.75 MCL1 (0.45) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL3672345 0.73 KDM4E (0.43) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL6695575 0.73 KDM4E (0.51) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL3676539 0.73 MCL1 (0.43) ALDH1A1KDM4EHPGDGALR3GAA
Water SCHEMBL4777584 0.73 GRIA1 (0.47) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL2918049 0.73 GRIA1 (0.47) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL3677714 0.72 TGFBR1 (0.42) ALDH1A1KDM4EHPGDGALR3GAA
SCHEMBL3976737 0.72 MCL1 (0.44) ALDH1A1KDM4EHPGDGAAMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254577-A1 AMPA RECEPTOR ANTAGONISTS FOR EPILEPSY, MENTAL DISORDERS OR DEFICITS IN SENSORY ORGAN Eisai R&D Management Co., Ltd. (JP) 2010-12-01 EP disclosed
EP-2164489-A2 COMBINATION OF AMPA RECEPTOR ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN Eisai R&D Management Co., Ltd. (JP) 2010-03-24 EP disclosed
EP-2131828-A2 AMPA AND NMDA RECEPTOR ANTAGONISTS FOR NEURODEGENERATIVE DISEASES Eisai R&D Management Co., Ltd. (JP) 2009-12-16 EP disclosed
WO-2009082039-A1 AMPA RECEPTOR ANTAGONISTS FOR EPILEPSY, MENTAL DISORDERS OR DEFICITS IN SENSORY ORGAN EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-07-02 WO disclosed
WO-2009054543-A1 AMPA RECEPTOR ANTAGONISTS AND ZONISAMIDE FOR PARKINSON'S DISEASE AND MOVEMENT DISORDERS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-04-30 WO disclosed
WO-2009054544-A1 AMPA RECEPTOR ANTAGONISTS FOR PARKINSON'S DISEASE AND MOVEMENT DISORDERS EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-04-30 WO disclosed
WO-2009011412-A2 COMBINATION OF AMPA RECEPTOR ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHIC PAIN EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-01-22 WO disclosed
WO-2008111590-A2 AMPA AND NMDA RECEPTOR ANTAGONISTS FOR NEURODEGENERATIVE DISEASES EISAI R & D MANAGEMENT CO., LTD. (JP) 2008-09-18 WO disclosed